Akero Therapeutics Inc.

AKRO | NASDAQ

Price Alert Chart Builder DCF Calculator

$54.65

$0 (0.00%)

At close: Dec 9, 2025, 4:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $4.5B

Enterprise Value $3.76B

Beta -0.40

Average Volume 2.29M

Shares Outstanding (Diluted) 81.72M

Shares Change YoY 18.1%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US00973Y1082

Price Performance

Price Change 1M 0.6%

Price Change 3M 14.2%

Price Change 6M -0.7%

Price Change YTD 94.6%

Price Change 1Y 92.6%

Price Change 3Y N/A

Price Change 5Y 109.6%

1M CAGR (ann.) 1.5%

1Y CAGR (ann.) 84.0%

5Y CAGR (ann.) 14.1%

All-Time CAGR 18.4%

Valuation

PE Ratio -14.38

Forward PE N/A

PEG Ratio -88.50

Forward PEG -4.17

PS Ratio 1,124,684.53

Forward PS 232.60

PB Ratio 4.70

P/FCF Ratio -17.75

P/Adj. FCF Ratio -15.73

P/OCF Ratio -24.51

EV/Sales 940,519.03

EV/EBIT -13.48

EV/EBITDA -13.48

EV/FCF -14.84

Earnings Yield -7.0%

FCF Yield -5.6%

Adj. FCF Yield -6.4%

Financial Health

Net Cash $736.95M

Total Debt $1.16M

Cash & Short-Term Investments $737.83M

Total Assets $1.01B

Current Ratio 15.83

Quick Ratio 15.83

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt -217.72

Interest Coverage -73.72

Altman Z-Score 54.77

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin -8037075.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin -6335600.0%

Adj. FCF Margin -7147675.0%

SBC / Revenue 0.0%

SBC Impact (per share) -12.8%

Returns

Return on Assets -22.2%

Return on Equity -21.8%

Return on Invested Capital -26.3%

Return on Capital Employed -26.3%

Return on Tangible Assets -22.2%

Historical Growth (CAGR)

Revenue CAGR 3Y 2.1%

Revenue CAGR 5Y 50.7%

Revenue CAGR 10Y N/A

EPS CAGR 3Y -21.0%

EPS CAGR 5Y -7.6%

EPS CAGR 10Y N/A

FCF CAGR 3Y -43.2%

FCF CAGR 5Y -33.1%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 14

EPS Growth Next 3Y 40.4%

Revenue Growth Next 3Y 4821.9%

Earnings Date Nov 6, 2025

EPS Estimate (next Q) -$0.94

EPS Growth Est (next Q) -10.5%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $48.40

Price Target Upside -11.4%

Cash Flow

Operating Cash Flow $-253.42M

Free Cash Flow $-253.42M

Adj. Free Cash Flow $-285.91M

FCF Per Share -$2.23

OCF Per Share -$2.23

OCF/S Ratio 0.0%

Income Statement

Revenue $4K

Gross Profit $1K

Operating Income $-321.48M

EBITDA $-279.17M

Net Income $-283.96M

EPS (Diluted) -$3.80

Revenue / Employee $57.97

Profit / Employee $-4.12M

Employees 69